What happened
Access Bio disclosed a supply contract with The Procter & Gamble Manufacturing Company, worth US$3.74M, about 15.89% of its recent annual revenue, running through Oct 2027.
For context, this single contract equals about 15.89% of the company's most recent annual revenue.
| Counterparty | The Procter & Gamble Manufacturing Company |
|---|---|
| Contract value | US$3.74M |
| vs. recent revenue | 15.89% |
| Through | Oct 2027 (from Oct 2026) |
| Filed | 2026-10-20, Supply contract signed |
| Source | DART rcept 20261020900298 → open original filing |
Source: DART. Information only, not investment advice.